Your browser doesn't support javascript.
loading
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Gagelmann, Nico; Eikema, Dirk-Jan; Koster, Linda; Netelenbos, Tanja; McDonald, Andrew; Stoppa, Anne-Marie; Fenk, Roland; Anagnostopoulos, Achilles; van Gorkom, Gwendolyn; Deconinck, Eric; Bulabois, Claude-Eric; Delforge, Michel; Bunjes, Donald; Arcese, William; Reményi, Péter; Itälä-Remes, Maija; Thurner, Lorenz; Bolaman, Ali Zahit; Nabil, Yafour; Lund, Johan; Labussière-Wallet, Hélène; Hayden, Patrick J; Beksac, Meral; Schönland, Stefan; Yakoub-Agha, Ibrahim.
Afiliação
  • Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Eikema DJ; Department of Statistics, Leiden University Medical Centre, Leiden, The Netherlands.
  • Koster L; EBMT Data Office, Leiden, The Netherlands.
  • Netelenbos T; Haga Teaching Hospital, Hague, The Netherlands.
  • McDonald A; Alberts Cellular Therapy, Pretoria East Hospital, Pretoria, South Africa.
  • Stoppa AM; Institut Paoli Calmettes, Marseille, France.
  • Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Anagnostopoulos A; Department of Hematology and HCT Unit, G. Papanikolaou Hospital, Thessaloniki, Greece.
  • van Gorkom G; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Deconinck E; Clinical Hematology, Besançon University Hospital, Besançon, France.
  • Bulabois CE; Service d'Hematologie, CHU Grenoble Alpes-Universite Grenoble Alpes, Grenoble, France.
  • Delforge M; University Hospital Leuven, Leuven, Belgium.
  • Bunjes D; Department of Internal Medicine III, Bone Marrow Transplantation Unit, University Hospital of Ulm, Ulm, Germany.
  • Arcese W; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Reményi P; St. István and St. László Hospital of Budapest, Budapest, Hungary.
  • Itälä-Remes M; Turku University Hospital, Stem Cell Transplantation Unit, Turku, Finland.
  • Thurner L; Department of Oncology, Hematology, Rheumatology and Clinical Immunology, Saarland University Medical Center, Homburg, Germany.
  • Bolaman AZ; Internal Medicine, Division of Hematology, Adnan Menderes University, Aydin, Turkey.
  • Nabil Y; Établissement hospitalier et universitaire, Service d'hématologie et de thérapie cellulaire, Université d'Oran 1, Ahmed Ben Bella, faculté de médecine, Oran, Algeria.
  • Lund J; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Institute & University Hospital, Stockholm, Sweden.
  • Labussière-Wallet H; Service d'Hématologie, Hôpital Lyon Sud, Pierre Bénite, France.
  • Hayden PJ; Department of Haematology, St. James's Hospital, Dublin, Ireland.
  • Beksac M; Cebeci Yerleskesi Dikimevi, Ankara, Turkey.
  • Schönland S; Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany.
  • Yakoub-Agha I; INSERM U1286, Centre Hospitalier Universitaire de Lille LIRIC, Lille, France.
Eur J Haematol ; 111(2): 181-190, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37082839
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Idioma: En Ano de publicação: 2023 Tipo de documento: Article